FDA upgrades approach to certifying new AI products

The Food and Drug Administration (FDA) has released its first ever guidance on how it plans to work toward a more streamlined and timely approval of artificial intelligence and other digital health products. The Digital Health Innovation Action Plan, released Jan. 7, is part of FDA’s Pre-Cert Pilot Program to review products, including AI, and is another step in a […]

Read more